These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

340 related items for PubMed ID: 10377387

  • 1. Identification of SH2-bbeta as a potent cytoplasmic activator of the tyrosine kinase Janus kinase 2.
    Rui L, Carter-Su C.
    Proc Natl Acad Sci U S A; 1999 Jun 22; 96(13):7172-7. PubMed ID: 10377387
    [Abstract] [Full Text] [Related]

  • 2. Differential binding to and regulation of JAK2 by the SH2 domain and N-terminal region of SH2-bbeta.
    Rui L, Gunter DR, Herrington J, Carter-Su C.
    Mol Cell Biol; 2000 May 22; 20(9):3168-77. PubMed ID: 10757801
    [Abstract] [Full Text] [Related]

  • 3. Identification of SH2-Bbeta as a substrate of the tyrosine kinase JAK2 involved in growth hormone signaling.
    Rui L, Mathews LS, Hotta K, Gustafson TA, Carter-Su C.
    Mol Cell Biol; 1997 Nov 22; 17(11):6633-44. PubMed ID: 9343427
    [Abstract] [Full Text] [Related]

  • 4. YXXL motifs in SH2-Bbeta are phosphorylated by JAK2, JAK1, and platelet-derived growth factor receptor and are required for membrane ruffling.
    O'Brien KB, Argetsinger LS, Diakonova M, Carter-Su C.
    J Biol Chem; 2003 Apr 04; 278(14):11970-8. PubMed ID: 12551917
    [Abstract] [Full Text] [Related]

  • 5. SH2-B is required for growth hormone-induced actin reorganization.
    Herrington J, Diakonova M, Rui L, Gunter DR, Carter-Su C.
    J Biol Chem; 2000 Apr 28; 275(17):13126-33. PubMed ID: 10777618
    [Abstract] [Full Text] [Related]

  • 6. Increased SH2-Bbeta content and membrane association in transgenic mice overexpressing GH.
    Miquet JG, Sotelo AI, Bartke A, Turyn D.
    J Endocrinol; 2005 May 28; 185(2):301-6. PubMed ID: 15845922
    [Abstract] [Full Text] [Related]

  • 7. Growth hormone receptor cytoplasmic domain differentially promotes tyrosine phosphorylation of signal transducers and activators of transcription 5b and 3 by activated JAK2 kinase.
    Yi W, Kim SO, Jiang J, Park SH, Kraft AS, Waxman DJ, Frank SJ.
    Mol Endocrinol; 1996 Nov 28; 10(11):1425-43. PubMed ID: 8923468
    [Abstract] [Full Text] [Related]

  • 8. The role of the growth hormone (GH) receptor and JAK1 and JAK2 kinases in the activation of Stats 1, 3, and 5 by GH.
    Smit LS, Meyer DJ, Billestrup N, Norstedt G, Schwartz J, Carter-Su C.
    Mol Endocrinol; 1996 May 28; 10(5):519-33. PubMed ID: 8732683
    [Abstract] [Full Text] [Related]

  • 9. Mutation of the SHP-2 binding site in growth hormone (GH) receptor prolongs GH-promoted tyrosyl phosphorylation of GH receptor, JAK2, and STAT5B.
    Stofega MR, Herrington J, Billestrup N, Carter-Su C.
    Mol Endocrinol; 2000 Sep 28; 14(9):1338-50. PubMed ID: 10976913
    [Abstract] [Full Text] [Related]

  • 10. SH2-B family members differentially regulate JAK family tyrosine kinases.
    O'Brien KB, O'Shea JJ, Carter-Su C.
    J Biol Chem; 2002 Mar 08; 277(10):8673-81. PubMed ID: 11751854
    [Abstract] [Full Text] [Related]

  • 11. Growth hormone-induced tyrosyl phosphorylation and deoxyribonucleic acid binding activity of Stat5A and Stat5B.
    Smit LS, Vanderkuur JA, Stimage A, Han Y, Luo G, Yu-Lee LY, Schwartz J, Carter-Su C.
    Endocrinology; 1997 Aug 08; 138(8):3426-34. PubMed ID: 9231797
    [Abstract] [Full Text] [Related]

  • 12. SH2-B and SIRP: JAK2 binding proteins that modulate the actions of growth hormone.
    Carter-Su C, Rui L, Stofega MR.
    Recent Prog Horm Res; 2000 Aug 08; 55():293-311. PubMed ID: 11036942
    [Abstract] [Full Text] [Related]

  • 13. SH2-B is required for nerve growth factor-induced neuronal differentiation.
    Rui L, Herrington J, Carter-Su C.
    J Biol Chem; 1999 Apr 09; 274(15):10590-4. PubMed ID: 10187854
    [Abstract] [Full Text] [Related]

  • 14. SH2-Bbeta is a Rac-binding protein that regulates cell motility.
    Diakonova M, Gunter DR, Herrington J, Carter-Su C.
    J Biol Chem; 2002 Mar 22; 277(12):10669-77. PubMed ID: 11786545
    [Abstract] [Full Text] [Related]

  • 15. Interaction of growth hormone-activated STATs with SH2-containing phosphotyrosine phosphatase SHP-1 and nuclear JAK2 tyrosine kinase.
    Ram PA, Waxman DJ.
    J Biol Chem; 1997 Jul 11; 272(28):17694-702. PubMed ID: 9211920
    [Abstract] [Full Text] [Related]

  • 16. Desensitization of the JAK2/STAT5 GH signaling pathway associated with increased CIS protein content in liver of pregnant mice.
    Miquet JG, Sotelo AI, Bartke A, Turyn D.
    Am J Physiol Endocrinol Metab; 2005 Oct 11; 289(4):E600-7. PubMed ID: 15899943
    [Abstract] [Full Text] [Related]

  • 17. PRL-induced ERalpha gene expression is mediated by Janus kinase 2 (Jak2) while signal transducer and activator of transcription 5b (Stat5b) phosphorylation involves Jak2 and a second tyrosine kinase.
    Frasor J, Barkai U, Zhong L, Fazleabas AT, Gibori G.
    Mol Endocrinol; 2001 Nov 11; 15(11):1941-52. PubMed ID: 11682625
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone-promoted tyrosyl phosphorylation of SHC proteins and SHC association with Grb2.
    VanderKuur J, Allevato G, Billestrup N, Norstedt G, Carter-Su C.
    J Biol Chem; 1995 Mar 31; 270(13):7587-93. PubMed ID: 7535773
    [Abstract] [Full Text] [Related]

  • 19. Negative regulation of growth hormone receptor/JAK2 signaling by signal regulatory protein alpha.
    Stofega MR, Argetsinger LS, Wang H, Ullrich A, Carter-Su C.
    J Biol Chem; 2000 Sep 08; 275(36):28222-9. PubMed ID: 10842184
    [Abstract] [Full Text] [Related]

  • 20. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins.
    Hansen JA, Lindberg K, Hilton DJ, Nielsen JH, Billestrup N.
    Mol Endocrinol; 1999 Nov 08; 13(11):1832-43. PubMed ID: 10551777
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 17.